# Validation of a New Device to Measure Neuromuscular Disease Progression

> **NCT00606918** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00606918
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606918, "Validation of a New Device to Measure Neuromuscular Disease Progression". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00606918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*